Key facts
- Notable investors include NCBR Investment Fund, The National Centre for Research and Development.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Orthoget
- ·The full record, as it builds
Funding rounds
No funding rounds for Orthoget are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Orthoget
Developer of orthopedic implant technology designed for limb lengthening and deformity correction. The company's platform integrates a magneto-mechanical intramedullary device with external activation and digital monitoring tools, enabling orthopedic specialists to achieve bone lengthening, maintain load-bearing functionality, and track treatment progress through real-time data for improved clinical outcomes and workflow efficiency.
- Sector
- Healthcare
- HQ
- Wrocław, Poland
- Founded
- 2017
- Employees
- 8
- Website
- orthoget.com/
- Ownership
- Privately Held (backing)
Orthoget doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Orthoget shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Orthoget in its N-PORT filings yet. We sweep new filings monthly.